Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
Mini-Med Technologies
Download detailed PDF Members: Medtronic MiniMed is a world leader in insulin pump therapy and continuous glucose monitoring. Our first insulin pump, the Model 502, was introduced in July of 1983. Remarkably, a number of people continue to wear the same pump they purchased more than a decade ago. Today over 150,000 people enjoy the benefits of our insulin pumps. Our Company is firmly committed to helping people living with diabetes live healthier and more normal lives by providing superior technology and responsive customer support. Medtronic MiniMed provides assistance to its customers 24 hours a day, 365 days a year through our clinical services hotline, and is committed to educating the health care community by providing accredited continuing educational programs on insulin pump therapy. This includes a nationwide symposia series for physician and nurse teams, and a certified pump trainer program. Medtronic MiniMed takes great pride in setting the industry standard for customer service, advanced technology and educational programs, and is committed to creating greater awareness of insulin pump therapy and continuous glucose monitoring for the treatment of diabetes.
This page has been viewed 1071 times since April 2007, the link to the organisation's website has been followed 0 times Recent Search Terms used to find this page: minimed technologies | Mini-Med Technologies | diabetes drug companies sylmar | MINI MED TECHNOLOGIES | minimed VISION | minimed | mini med tech | minimed technol | minimed new pumps 2009 | minimed customer service hours | . Search for more companies in Sylmar Search for more companies in CA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Mini-Med Technologies | ||||||||||||||||||||||||
|